DISPLACE研究显示经颅多普勒超声在镰状细胞贫血卒中风险筛查中的质量不佳
该研究为DISPLACE研究的亚分析,从28家机构收集超过12 000份经颅多普勒超声(TCD)/经颅多普勒成像(TCDi)报告,并复核其中391份TCD报告。结果显示,52%的报告无法确定所测的是否为时间平均最大平均速度(TAMMV),仅42%的报告明确以TAMMV解读检查正常或异常, vessels评估、异常速度阈值及判读者均存在显著差异。作者强烈推荐对TCD/TCDi报告进行标准化、对操作和判读者进行专项培训、开展内部质量保证及机构质量改进工作。
要点
- 52%的报告无法确定测量的指标是否为时间平均最大平均速度(TAMMV)。
- 仅42%的报告明确使用TAMMV将检查解读为正常或异常。
- 评估血管、异常速度阈值及判读者均存在显著差异。
核心结论
- 镰状细胞贫血患者的TCD/TCDi报告在测量指标、判读阈值和判读者方面存在显著差异,报告质量不佳;作者强烈推荐标准化报告、专项培训、内部质量保证及机构质量改进。
研究设计与样本
- DISPLACE(Dissemination and Implementation of Stroke Prevention Looking at the Care Environment)研究的亚分析;从28家机构收集超过12 000份TCD/TCDi报告,复核其中391份TCD报告。
主要发现
- 52%的报告无法确定所测的是否为TAMMV;仅42%的报告明确以TAMMV解读检查为正常或异常;评估血管、定义异常结果的速度值及判读者均存在显著差异。
关键数值与推荐
- STOP试验表明,使用TCD(Sickle Stroke Screen)联合慢性红细胞输注可使卒中风险降低超过90%。
- 52%的报告无法确定所测的是否为TAMMV。
- 仅42%的报告明确使用TAMMV将检查解读为正常或异常。
临床怎么用
- 作者强烈推荐对TCD/TCDi报告进行标准化、对在镰状细胞贫血患者中操作和判读扫描的人员进行专项培训、开展内部质量保证及机构质量改进工作,以确保恰当使用这一可能挽救生命的技术。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Children with sickle cell anemia (SCA) are at increased risk of stroke when compared with their age-based counterparts. The Stroke Prevention Trial in Sickle Cell Anemia (STOP) previously demonstrated that with the use of transcranial Doppler ultrasound (TCD; Sickle Stroke Screen) and chronic red cell transfusion, the risk of stroke is reduced by over 90%. The STOP criteria detailed the type and method of measurement required; the time-averaged mean maximum velocity (TAMMV). Unfortunately, it has been difficult to adhere to the appropriate TAMMV measurements. The objectives of this study were to assess the quality of TCD and transcranial Doppler imaging (TCDi) reports to determine the report quality and accuracy. This is a subanalysis of the DISPLACE (Dissemination and Implementation of Stroke Prevention Looking at the Care Environment) study. Over 12 000 TCD/TCDi reports were collected during this study from 28 institutions; 391 TCDs were reviewed for this subanalysis. There were significant variations in the vessels being assessed, the velocities used to define abnormal results, and who was interpreting the scans. In 52% of reports, it was impossible to identify whether the TAMMV was what was measured. Similarly, it was only clear in 42% of reports that the TAMMV was used to interpret the examination as normal/abnormal. Given this inconsistency, we strongly recommend standardization of TCD/TCDi reporting, specialized training for those performing and interpreting the scans in the use of TCD/TCDi in patients with SCA, internal quality assurance, and institutional quality improvement work to ensure appropriate use of this potentially lifesaving technology.
引用
- Davidow KA, Miller RE, Phillips SM, et al. DISPLACE study shows poor quality of transcranial doppler ultrasound for stroke risk screening in sickle cell anemia. Blood Adv. 2024. PMID: 38669350. doi:10.1182/bloodadvances.2024012631
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。